# Arifulla Khan MD - Inspection Records

Source: https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005

> Inspection records and compliance data for Arifulla Khan MD in Bellevue, Washington. Access full analysis and detailed observations.

---

## Details

- Name: Arifulla Khan MD
- FEI Number: 3003114854
- City: Bellevue
- State: Washington
- Country Name: United States
- Address Line 1: Northwest Clinical Research Center, 1951 152nd Pl Ne Ste 200
- Zip Code: 98007

## Related Documents

- [FDA Inspection 1242972 - Arifulla Khan MD - 2024-06-25](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/a9a367ad-26c4-44b6-b47a-2ff2d457576f) — classification: No Action Indicated (NAI), source: FDA, date: June 25, 2024
- [FDA Inspection 1208467 - Arifulla Khan MD - 2023-06-09](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/fbfad172-dbdd-440c-a6de-5e6ec472216f) — classification: No Action Indicated (NAI), source: FDA, date: June 9, 2023
- [FDA Inspection 1130374 - Arifulla Khan MD - 2020-08-31](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/4e85b814-29cc-40d8-998a-ea12c6c8c2fc) — classification: No Action Indicated (NAI), source: FDA, date: August 31, 2020
- [FDA Inspection 1130374 - Arifulla Khan MD - 2020-08-31](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/f93ebf0f-bb69-4ff3-aa9f-3dba727e13f4) — classification: No Action Indicated (NAI), source: FDA, date: August 31, 2020
- [FDA Inspection 1093597 - Arifulla Khan MD - 2019-06-07](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/1a553b51-4a4a-4f56-8219-47d5980280e4) — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2019
- [EIR - Arifulla Khan MD - 2014-06-11](https://www.keypedia.com/records/eir/arifulla-khan-md/103feb79-a8a8-4815-9167-0a344c156a67) — source: FDA, date: June 11, 2014
- [483 - Arifulla Khan MD - 2014-06-11](https://www.keypedia.com/records/483/arifulla-khan-md/86776fd3-10ae-4872-aa64-fce0d73af6b9) — source: FDA, date: June 11, 2014
- [FDA Inspection 885776 - Arifulla Khan MD - 2014-06-11](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/a328c5c1-520a-47c2-85ce-6b04ac091f04) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 11, 2014
- [FDA Inspection 821765 - Arifulla Khan MD - 2013-04-10](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/dde756d7-e0b2-4baf-808b-e4530a09ae0e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 10, 2013
- [FDA Inspection 776737 - Arifulla Khan MD - 2012-03-28](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/fee92fe9-8e25-44c0-9a3b-6a253f95a60b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2012
- [FDA Inspection 677940 - Arifulla Khan MD - 2010-08-24](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/ee684e3f-2ff3-40af-8234-a7a59593ea61) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2010
- [FDA Inspection 671178 - Arifulla Khan MD - 2010-07-01](https://www.keypedia.com/records/fda_inspections/arifulla-khan-md/985b6ab7-b382-4807-b0a5-f83c6d52cea3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 1, 2010

## Related Companies

- [Philips Respironics, Inc.](https://www.keypedia.com/companies/philips-respironics-inc/03ceee46-7a72-4590-8bc4-8033e1503cf3)
- [Reading Hospital](https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [Iridex Corporation](https://www.keypedia.com/companies/iridex-corporation/9c886e2b-8873-4b61-b8b2-468461ced7a5)
- [Biomedix Wai](https://www.keypedia.com/companies/biomedix-wai/35aa0e7f-c8eb-40a8-9b5b-5b57fa435abf)
- [American National Red Cross (The), Lewis and Clark Region](https://www.keypedia.com/companies/american-national-red-cross-the-lewis-and-clark-region/5dfd3f0f-7713-4681-89e8-a399d1dccf82)
- [Abbott Vascular](https://www.keypedia.com/companies/abbott-vascular/745759b5-fe3d-4e6e-a507-d84e0ed39f35)
- [Biomerieux Inc](https://www.keypedia.com/companies/biomerieux-inc/4ca56fd6-0bcf-4144-8cb6-60511d8260b4)
- [Carefusion Corporation](https://www.keypedia.com/companies/carefusion-corporation/fc68c359-74a3-4c78-844a-79b933b81f81)
- [Nutra Solutions USA, Inc.](https://www.keypedia.com/companies/nutra-solutions-usa-inc/c3b931f1-cf3d-4550-b715-a5e8554a01da)

## Related Officers

- [Senior Quality Engineer](https://www.keypedia.com/people/sharon-gundersen/5bc43dc9-a52b-4e19-b8c2-75fd37e8e175)
- [Marijo B. Kambere](https://www.keypedia.com/people/marijo-b-kambere/54e010f0-0d56-4b20-b5e2-112e372de58b)